OQS
ASMB icon

Occudo Quantitative Strategies’s Assembly Biosciences ASMB Stock Holding History

Occudo Quantitative Strategies’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,037
Closed -$20K – 952
2022
Q3 		$20K Buy
+1,037
New +$25.1K ﹤0.01% 1129
2021
Q3 		– Sell
-7,459
Closed -$347K – 1001
2021
Q2 		$347K Sell
7,459
-641
-8% -$31.8K 0.05% 542
2021
Q1 		$447K Buy
8,100
+3,883
+92% +$257K 0.1% 363
2020
Q4 		$306K Buy
+4,217
New +$495K 0.1% 409

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Occudo Quantitative Strategies's ASMB Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of Assembly Biosciences (ASMB) in Q4 2022, closing a stake of 1,037 shares — an estimated $20K sold.

Occudo Quantitative Strategies first reported a position in ASMB in Q4 2020 and held it in 4 quarters. The position peaked at $447K in Q1 2021. 39 funds tracked by Wall St. Rank hold ASMB as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining Assembly Biosciences position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 1,037 Assembly Biosciences shares in Q4 2022, an estimated $20K.
  • Occudo Quantitative Strategies first reported a position in Assembly Biosciences in Q4 2020 and held it in 4 quarters.
  • Occudo Quantitative Strategies's Assembly Biosciences position peaked at $447K in Q1 2021.
  • 39 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.